Rescindo Therapeutics Inc.
Rescindo Therapeutics, Inc. is a drug discovery & development company focused on rare genetic diseases, especially those affecting children.
Company Details
Company type
Year founded
2015
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Core capabilities
Potential end market(s)
Products under development
We currently have two programs in pre-clinical development; Kabuki Syndrome for which we have received Orphan Drug Designation from the FDA and Ciliopathies.